Commentary

AlphaNorth Asset Management CEO Steven Palmer sat down with James to talk about what companies the Toronto-based investment manager has invested in, including in the blockchain, AI, lithium, gold, and cannabis sectors. TRANSCRIPT: James West:     Steve, thanks for joining us today. Steve Palmer:     Thanks for having me. James West:     Steve, in your role as a fund manager, I’m curious as to how you view the Blockchain phenomenon generally and cryptocurrency specifically? Steve Palmer:     There’s a lot of opportunities in [...]
MidasLetter Live
New Cannabis Ventures and 420Investor CFA Alan Brockstein joins to talk about the emerging opportunities in the Cannabis space, and how investors need to watch out as the darker underbelly of capital markets are attracted to the rich valuations currently being experienced in certain issuers.

Within the text of Bill C-45 The Cannabis Act are sown the seeds for the program’s potential failure. The Liberal Government has limited time to change course and avoid both a price war and a flood [...]
James West

With self-congratulatory accolades flowing effusively from within America starting at the top with Donald Trump, it behooves the objective market participant to recall the reasons that have caused the Dow’s meteroic rise to [...]
James West

Cannabis Wheaton Income Corporation (CVE:CBW) (OTCMKTS:KWFLF) (FRA:3KF) is getting hammered today, as is MedReleaf on the first day of its IPO, despite having closed a $100 million financing. Cannabis Wheaton is already underwater [...]
James West

I cannot stress strongly enough the importance of understanding where the markets are currently technically located, with regards to different time frames and which help to guide all my trading and investing decisions. [...]
Chris Vermeulen

Free Newsletter,
Priceless Content.

Get more of Midas Letter delivered right to your inbox.

Special Offer

Sign-up today and receive free and immediate access to three recently published special reports!

Free Newsletter,
Priceless Content.

Get more of Midas Letter delivered right to your inbox.

Special Offer

Sign-up today and receive free and immediate access to three recently published special reports!